Abnormal serum levels of alanine aminotransferase (ALT) or aspartate aminotransferase (AST) occurred in 23.47% (315/1342) of patients treated for MTX-treated rheumatoid arthritis [21]. The gene discussed is GPT; the disease is rheumatoid arthritis.